CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test
Introduction
The CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test is a vital diagnostic tool designed to identify genetic mutations associated with early infantile epileptic encephalopathy (EIEE). This condition is characterized by severe seizures and developmental delays in infants. Understanding the genetic basis of EIEE can significantly impact treatment decisions and family planning.
What the Test Measures
This test utilizes Next-Generation Sequencing (NGS) technology to detect mutations in the CUX2 gene, which has been linked to neurological disorders. By analyzing the DNA from a blood sample or extracted DNA, the test can pinpoint specific genetic alterations that may contribute to the development of EIEE.
Who Should Consider This Test?
Parents and caregivers of infants displaying symptoms such as:
- Frequent seizures
- Developmental delays
- Unusual muscle tone
- Abnormal movements
are encouraged to consider this test. Additionally, families with a history of neurological disorders should consult a healthcare professional about genetic testing options.
Benefits of Taking the Test
- Identifies genetic causes of epilepsy, aiding in accurate diagnosis.
- Informs treatment strategies and interventions for affected infants.
- Facilitates genetic counseling and family planning.
- Provides peace of mind for families regarding the health of their child.
Understanding Your Results
Results from the CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test will be interpreted by a qualified neurologist. A positive result indicates a genetic mutation linked to EIEE, while a negative result suggests that the CUX2 gene is not involved. It is essential to discuss the implications of your results with a healthcare provider.
Test Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test | KSh 40,000 | KSh 56,000 |
Branches and Booking
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. Our team is ready to assist you with home sample collection services for your convenience.
To book the CUX2 Gene Early Infantile Epileptic Encephalopathy Type 67 NGS Genetic DNA Test, please call or WhatsApp us at +254713408028.